Given the significant and distinct roles of the RIP1-RIP3-MLKL axis in metabolic diseases of various etiologies, researchers have investigated the potential of circulating concentrations of RIP1, RIP3, and MLKL as potential biomarkers in humans. Here, RIPK1 is linked to metabolic disease.